Works matching IS 14783223 AND DT 2024 AND VI 44 AND IP 6

Results: 26
    1

    Cover Image.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. i, doi. 10.1111/liv.15983
    By:
    • Guan, Yuan;
    • Peltz, Gary
    Publication type:
    Article
    2

    Issue Information.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1269, doi. 10.1111/liv.15978
    Publication type:
    Article
    3
    4

    Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1456, doi. 10.1111/liv.15907
    By:
    • Kikuchi, Tatsuya;
    • Takeuchi, Yasuto;
    • Nouso, Kazuhiro;
    • Kariyama, Kazuya;
    • Kuwaki, Kenji;
    • Toshimori, Junichi;
    • Iwado, Shota;
    • Moriya, Akio;
    • Hagihara, Hiroaki;
    • Takabatake, Hiroyuki;
    • Tada, Toshifumi;
    • Yasunaka, Tetsuya;
    • Sakata, Masahiro;
    • Sue, Masahiko;
    • Miyake, Nozomi;
    • Adachi, Takuya;
    • Wada, Nozomu;
    • Onishi, Hideki;
    • Shiraha, Hidenori;
    • Takaki, Akinobu
    Publication type:
    Article
    5
    6

    Upfront multi‐bipolar radiofrequency ablation for HCC in transplant‐eligible cirrhotic patients with salvage transplantation in case of recurrence.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1464, doi. 10.1111/liv.15900
    By:
    • Boros, Carina;
    • Sutter, Olivier;
    • Cauchy, François;
    • Ganne‐Carrié, Nathalie;
    • Nahon, Pierre;
    • N'kontchou, Gisele;
    • Ziol, Marianne;
    • Grando, Véronique;
    • Demory, Alix;
    • Blaise, Lorraine;
    • Dondero, Fédérica;
    • Durand, François;
    • Soubrane, Olivier;
    • Lesurtel, Mickael;
    • Laurent, Alexis;
    • Seror, Oliver;
    • Nault, Jean Charles
    Publication type:
    Article
    7

    An optimized short‐term steroid therapy for chronic drug‐induced liver injury: A prospective randomized clinical trial.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1435, doi. 10.1111/liv.15899
    By:
    • Huang, Ang;
    • Zhu, Yun;
    • Liu, Shuhong;
    • Sun, Ying;
    • Liu, Zherui;
    • Liang, Qing‐sheng;
    • Zhao, Jun;
    • Chang, Bin‐xia;
    • Bi, Jing‐feng;
    • Liu, Jiang‐tao;
    • Zhai, Xing‐ran;
    • Xie, Huan;
    • Li, Ning;
    • Tian, Hui;
    • Han, Lin;
    • Zhuang, Yingjie;
    • Ma, Hongbin;
    • Teng, Guang‐ju;
    • Zhang, Wei;
    • Aithal, Guruprasad P.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1422, doi. 10.1111/liv.15873
    By:
    • Chen, Huey‐Ling;
    • Lee, Chien‐Nan;
    • Chang, Chin‐Hao;
    • Lai, Ming‐Wei;
    • Tsai, Ming‐Chieh;
    • Mu, Shu‐Chi;
    • Liu, Chun‐Jen;
    • Shih, Jin‐Chung;
    • Wen, Wan‐Hsin;
    • Hu, Rui‐Ting;
    • Huang, Chun‐Pin;
    • Hu, Kuang‐Chun;
    • Chen, Chie‐Pein;
    • Lee, Chyi‐Long;
    • Chien, Rong‐Nan;
    • Chang, Kai‐Chi;
    • Hsu, Hong‐Yuan;
    • Lee, Chien‐Chang;
    • Ni, Yen‐Hsuan;
    • Chang, Mei‐Hwei
    Publication type:
    Article
    20
    21

    Multitask deep learning for prediction of microvascular invasion and recurrence‐free survival in hepatocellular carcinoma based on MRI images.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1351, doi. 10.1111/liv.15870
    By:
    • Wang, Fang;
    • Zhan, Gan;
    • Chen, Qing‐qing;
    • Xu, Hou‐yun;
    • Cao, Dan;
    • Zhang, Yuan‐yuan;
    • Li, Yin‐hao;
    • Zhang, Chu‐jie;
    • Jin, Yao;
    • Ji, Wen‐bin;
    • Ma, Jian‐bing;
    • Yang, Yun‐jun;
    • Zhou, Wei;
    • Peng, Zhi‐yi;
    • Liang, Xiao;
    • Deng, Li‐ping;
    • Lin, Lan‐fen;
    • Chen, Yen‐wei;
    • Hu, Hong‐jie
    Publication type:
    Article
    22
    23
    24

    Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1343, doi. 10.1111/liv.15825
    By:
    • Kobayashi, Satoshi;
    • Fukushima, Taito;
    • Ueno, Makoto;
    • Chuma, Makoto;
    • Numata, Kazushi;
    • Tsuruya, Kota;
    • Arase, Yoshitaka;
    • Hirose, Shunji;
    • Kagawa, Tatehiro;
    • Hattori, Nobuhiro;
    • Watanabe, Tsunamasa;
    • Matsunaga, Kotaro;
    • Uojima, Haruki;
    • Hidaka, Hisashi;
    • Kusano, Chika;
    • Morimoto, Manabu;
    • Maeda, Shin
    Publication type:
    Article
    25

    Recipient age influences survival after liver transplant: Results of the French national cohort 2007–2017.

    Published in:
    Liver International, 2024, v. 44, n. 6, p. 1396, doi. 10.1111/liv.15867
    By:
    • Lerosey, Lea;
    • Ksiasek, Elea;
    • Abrahamowicz, Michal;
    • Antoine, Corinne;
    • Dharancy, Sébastien;
    • Dumortier, Jérôme;
    • Doussot, Alexandre;
    • Di Martino, Vincent;
    • Houssel‐Debry, Pauline;
    • Conti, Filomena;
    • Francoz, Claire;
    • Pageaux, Georges‐Philippe;
    • Salame, Ephrem;
    • Faitot, François;
    • Coilly, Audrey;
    • Hardwigsen, Jean;
    • Decaens, Thomas;
    • Chermak, Faiza;
    • Muscari, Fabrice;
    • Anty, Rodolphe
    Publication type:
    Article
    26